T-bet, pSTAT1 and pSTAT3 expression in peripheral blood mononuclear cells during pregnancy correlates with post-partum activation of multiple sclerosis

Clinical Immunology

Volumn 131, Issue 1, 2009, Pages 70-83

  Iorio, R ^a   Frisullo, G ^a   Nociti, V ^a,b   Patanella, K A ^a,b   Bianco, A ^a   Marti, A ^a   Mirabella, M ^a   Tonali, P A ^a,b   Batocchi, A P ^a,b  

^a CATHOLIC UNIVERSITY   (Italy)

^b IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

Foxp3; Multiple sclerosis; Pregnancy; pSTAT1; pSTAT3; T regulatory cells; T bet; Transcription factors

Indexed keywords

CD14 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 17; STAT1 PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR T BET;

ADOLESCENT; ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MONOCYTE; MULTIPLE SCLEROSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUERPERIUM; REGULATORY T LYMPHOCYTE; RELAPSE;

ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-17; LONGITUDINAL STUDIES; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; T-BOX DOMAIN PROTEINS; T-LYMPHOCYTES, REGULATORY;

EID: 63549098368     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2008.10.013     Document Type: Article

References (36)

1. Rouas-Freiss N., Gonçalves R.M., Menier C., Dausset J., and Carosella E.D. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 11520-11525
2. Munn D.H., Zhou M., Attwood J.T., Bondarev I., Conway S.J., Marshall B., Brown C., and Mellor A.L. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281 (1998) 1191-1193
3. Mellor A.L., and Munn D.H. Immunology at the maternal-fetal interface: lessons for T cell tolerance and suppression. Annu. Rev. Immunol. 18 (2000) 367-391
4. Mellor A.L., Sivakumar J., Chandler P., Smith K., Molina H., Mao D., and Munn D.H. Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat. Immunol. 2 (2001) 64-68
5. Xu C., Mao D., Holers V.M., Palanca B., Cheng A.M., and Molina H. A critical role for murine complement regulator crry in fetomaternal tolerance. Science 287 (2000) 498-501
6. Makrigiannakis A., Zoumakis E., Kalantaridou S., Coutifaris C., Margioris A.N., Coukos G., Rice K.C., Gravanis A., and Chrousos G.P. Corticotropin-releasing hormone promotes blastocyst implantation and early maternal tolerance. Nat. Immunol. 2 (2001) 1018-1024
7. Lin H., Mosmann T.R., Guilbert L., Tuntipopipat S., and Wegmann T.G. Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J. Immunol. 151 (1993) 4562-4573
8. Bebo Jr. B.F., and Dveksler G.S. Evidence that pregnancy specific glycoproteins regulate T-Cell function and inflammatory autoimmune disease during pregnancy. Curr. Drug. Targets Inflamm. Allergy 4 (2005) 231-237
9. Clark D.A., Blois S., Kandil J., Handjiski B., Manuel J., and Arck P.C. Reduced uterine indoleamine 2,3-dioxygenase versus increased Th1/Th2 cytokine ratios as a basis for occult and clinical pregnancy failure in mice and humans. Am. J. Reprod. Immunol. 54 (2005) 203-216
10. Dosiou C., and Giudice L.C. Natural killer cells in pregnancy and recurrent pregnancy loss: endocrine and immunologic perspectives. Endocr. Rev. 26 (2005) 44-62
11. Irony-Tur-Sinai M., Vlodavsky I., Ben-Sasson S.A., Pinto F., Sicsic C., and Brenner T. Amelioration of autoimmune neuroinflammation by recombinant human alpha-fetoprotein. Exp. Neurol. 198 (2006) 136-144
12. Blois S.M., Ilarregui J.M., Tometten M., Garcia M., Orsal A.S., Cordo-Russo R., Toscano M.A., Bianco G.A., Kobelt P., Handjiski B., Tirado I., Markert U.R., Klapp B.F., Poirier F., Szekeres-Bartho J., Rabinovich G.A., and Arck P.C. A pivotal role for galectin-1 in fetomaternal tolerance. Nat. Med. 13 (2007) 1450-1457
13. Somerset D.A., Zheng Y., Kilby M.D., Sansom D.M., and Drayson M.T. Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology 112 (2004) 38-43
14. Confavreux C., Hutchinson M., Hours M.M., Cortinovis-Tourniaire P., and Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in multiple sclerosis group. N. Engl. J. Med. 339 (1998) 285-291
15. Sospedra M., and Martin R. Immunology of multiple sclerosis. Annu. Rev. Immunol. 23 (2005) 683-747
16. Komiyama Y., Nakae S., Matsuki T., Nambu A., Ishigame H., Kakuta S., Sudo K., and Iwakura Y. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177 (2006) 566-573
17. Lighvani A.A., Frucht D.M., Jankovic D., Yamane H., Aliberti J., Hissong B.D., Nguyen B.V., Gadina M., Sher A., Paul W.E., O J.J., and Shea. T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 15137-15142
18. Bettelli E., Korn T., Oukka M., and Kuchroo V.K. Induction and effector functions of T(H)17 cells. Nature 453 (2008) 1051-1057
19. Stumhofer J.S., Silver J.S., Laurence A., Porrett P.M., Harris T.H., Turka L.A., Ernst M., Saris C.J., O J.J., Shea, and Hunter C.A. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat. Immunol. 8 (2007) 1363-1371
20. Frisullo G., Angelucci F., Caggiula M., Nociti V., Iorio R., Patanella A.K., Sancricca C., Mirabella M., Tonali P.A., and Batocchi A.P. pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity. J. Neurosci. Res. 84 (2006) 1027-1036
21. Frisullo G., Nociti V., Iorio R., Patanella A.K., Bianco A., Caggiula M., Sancricca C., Tonali P.A., Mirabella M., and Batocchi A.P. Glucocorticoid treatment reduces T-bet and pSTAT1 expression in mononuclear cells from relapsing remitting multiple sclerosis patients. Clin. Immunol 124 (2007) 284-293
22. Saraste M., Väisänen S., Alanen A., and Airas L. Finnish multiple sclerosis and pregnancy study group, clinical and immunologic evaluation of women with multiple sclerosis during and after pregnancy. Gend. Med. 4 (2007) 45-55
23. Bielekova B., Catalfamo M., Reichert-Scrivner S., Packer A., Cerna M., Waldmann T.A., McFarland H., Henkart P.A., and Martin R. Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 5941-5946
24. Airas L., Saraste M., Rinta S., Elovaara I., Huang Y.H., and Wiendl H. Finnish multiple sclerosis and pregnancy study group, immunoregulatory factors in multiple sclerosis patients during and after pregnancy: relevance of natural killer cells. Clin. Exp. Immunol. 151 (2008) 235-243
25. Airas L., Nikula T., Huang Y.H., Lahesmaa R., and Wiendl H. Postpartum-activation of multiple sclerosis is associated with down-regulation of tolerogenic HLA-G. J. Neuroimmunol. 187 (2007) 205-211
26. Zhu W.H., Lu C.Z., Huang Y.M., Link H., and Xiao B.G. A putative mechanism on remission of multiple sclerosis during pregnancy: estrogen-induced indoleamine 2,3-dioxygenase by dendritic cells. Mult. Scler. 13 (2007) 33-40
27. Aluvihare V.R., Kallikourdis M., and Betz A.G. Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol. 5 (2004) 266-271
28. Campbell D.J., and Ziegler S.F. FOXP3 modifies the phenotypic and functional properties of regulatory T cells. Nat. Rev., Immunol. 7 (2007) 305-310
29. McCracken S.A., Hadfield K., Rahimi Z., Gallery E.D., and Morris J.M. NF-kB-regulated suppression of T-bet in T cells represses Th1 immune responses in pregnancy. Eur. J. Immunol. 37 (2007) 1386-1396
30. Ng S.C., Gilman-Sachs A., Thaker P., Beaman K.D., Beer A.E., and Kwak-Kim J. Expression of intracellular Th1 and Th2 cytokines in women with recurrent spontaneous abortion, implantation failures after IVF/ET or normal pregnancy. Am. J. Reprod. Immunol. 48 (2002) 77-86
31. Al-Shammri S., Rawoot P., Azizieh F., AbuQoora A., Hanna M., Saminathan T.R., and Raghupathy R. Th1/Th2 cytokine patterns and clinical profiles during and after pregnancy in women with multiple sclerosis. J. Neurol. Sci. 222 (2004) 21-27
32. McClain M.A., Gatson N.N., Powell N.D., Papenfuss T.L., Gienapp I.E., Song F., Shawler T.M., Kithcart A., and Whitacre C.C. Pregnancy suppresses experimental autoimmune encephalomyelitis through immunoregulatory cytokine production. J. Immunol. 179 (2007) 8146-8152
33. Vukusic S., Hutchinson M., Hours M., Moreau T., Cortinovis-Tourniaire P., Adeleine P., and Confavreux C. The pregnancy in multiple sclerosis group; pregnancy in multiple sclerosis group, pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain 127 (2004) 1353-1360
34. Paavilainen T., Kurki T., Parkkola R., Färkkilä M., Salonen O., Dastidar P., Elovaara I., and Airas L. Magnetic resonance imaging of the brain used to detect early post-partum activation of multiple sclerosis. Eur. J. Neurol. 14 (2007) 1216-1221
35. Brewster J.A., Orsi N.M., Gopichandran N., McShane P., Ekbote U.V., and Walker J.J. Gestational effects on host inflammatory response in normal and pre-eclamptic pregnancies. Eur. J. Obstet., Gynecol., Reprod. Biol. 140 1 (2008) 21-26
36. Orsi N.M., Gopichandran N., Ekbote U.V., and Walker J.J. Murine serum cytokines throughout the estrous cycle, pregnancy and post partum period. Anim. Reprod. Sci. 96 (2006) 54-65